Stocks in play: Small Pharma Inc.
Baystreet - Wed Jan 25, 8:47AM CST
Wed Jan 25, 8:47AM CST
Announces that SPL026, intravenous N,N-Dimethyltryptamine, with supportive therapy for the treatment ...
Canadian Patent Grant Strengthens Small Pharma’s International Position
Globe Newswire - Wed Aug 3, 2022
Wed Aug 3, 2022
Further Composition of Matter protection for SPL028, the Company’s next candidate expected to enter the clinic...
U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation
Globe Newswire - Tue Jul 26, 2022
Tue Jul 26, 2022
Key U.S. patent protection on injectable delivery of DMT in lead programs SPL026 and SPL028 LONDON, July 26, 2022 (GLOBE NEWSWIRE) -- Small Pharma...